AOD-9604 research guide

AOD-9604 in Singapore — Sourcing Guide

Research-grade AOD-9604 sourcing guide for Singapore. COA verification, vendor selection, and handling protocols.

Browse Regions Order AOD-9604 →

Sourcing AOD-9604 in Singapore

Research peptides like AOD-9604 sit in a recognised grey zone across most countries: unapproved as drugs, unscheduled as controlled compounds, and importable for legitimate research purposes in most markets. What varies by country is import procedures, customs handling, and vendor shipping experience with the destination country — the COA verification requirements are universal. The analytical framework — interpreting HPLC chromatograms, assessing mass spec data, checking endotoxin panels — is equally valid for every vendor serving Singapore and is the consistent core of responsible sourcing practice. What follows combines the core COA evaluation methodology with notes relevant to Singapore import and shipping.

Understanding AOD-9604 — Evidence Overview

The regulatory status of GHS compounds like AOD-9604 varies by country and has evolved over time. Some compounds in this class have been or are being investigated as pharmaceutical candidates — Sermorelin has been used clinically in GH deficiency treatment, and MK-677 (Ibutamoren) is an oral GHS that has undergone phase 2 clinical trials. This mixed pharmaceutical-research status means Singapore researchers should verify the specific regulatory status of AOD-9604 in their jurisdiction, as compounds with pharmaceutical development history may face different import regulations than pure research compounds. Singapore's health authority website is the definitive source for current status.

Order AOD-9604 in Singapore
COA-verified · Ships to Singapore · International tracking
Order Now →

Browse by Region

Top Cities in Singapore

Singapore AOD-9604 Sourcing Guide

Pricing benchmarks help Singapore researchers evaluate whether a AOD-9604 vendor is cutting corners — standard research-grade AOD-9604 should be comparable to established market pricing, and significantly below-market pricing almost always signals compromises. The COA verification step that Singapore researchers frequently overlook is checking that the batch number on the COA corresponds to the lot number on the received vial — a COA is only meaningful when it is specific to the exact lot in hand. Community forums that include members based in Singapore are a useful source of current, location-specific vendor experience — look for discussions specifically from Singapore community members for the most current and location-specific information. Avoid beginning protocols with hard delivery deadlines without sufficient product already in storage given the inherent unpredictability of international delivery.

Research Safety for AOD-9604

The most significant quality-related safety concern for AOD-9604 is bacterial endotoxin contamination — verify endotoxin testing is included in your batch COA ahead of any protocol involving administration. Storage requirements: lyophilised AOD-9604 at freezer temperature (−20°C), reconstituted solution refrigerated at 2-8°C and used within 4 weeks — reconstitute only with sterile bacteriostatic water. From a pure handling safety perspective, AOD-9604 presents standard research compound handling considerations — sterile technique, appropriate storage, and COA-confirmed sourcing are the central safety elements.

Order AOD-9604 — ships to Singapore
COA-verified · International shipping · All compounds research grade
Order Now →

Frequently Asked Questions

What is the clinical trial history of AOD-9604?

AOD-9604 has undergone multiple Phase II clinical trials for obesity treatment by Metabolic Pharmaceuticals in Australia. The trials showed safety and tolerability but mixed efficacy results for weight loss. It holds GRAS (Generally Recognized As Safe) status from the FDA for food use, which is unusual for research peptides.

How does AOD-9604 differ from growth hormone?

AOD-9604 contains only the fat-metabolism-relevant fragment of growth hormone (the C-terminal region) without the IGF-1-stimulating N-terminal domain. This means it targets fat cells' beta-adrenergic receptors for lipolytic effects without producing the anabolic IGF-1 signaling associated with full-length GH.

What is AOD-9604?

AOD-9604 is a synthetic peptide analogue of the C-terminal fragment of human growth hormone (amino acids 177-191), with an additional tyrosine residue at the N-terminus. It has been studied for fat metabolism effects, specifically lipolysis stimulation and lipogenesis inhibition, without the IGF-1-stimulating effects of full-length GH. It has undergone clinical trials for obesity treatment.